NR3C2 and hydrops fetalis: In a previous proteomic analysis of spironolactone, a steroidal MR antagonist, for patients at risk of HF [39], spironolactone therapy also increased several proteins from the Olink® Target 96 Cardiovascular II, Cardiovascular III, and Inflammation panels.